Pioneer in the chronic respiratory diseases sector, Rheonova opens its capital

Christelle Lamoine et Jérémy Patarin, fondateurs de Rheonova

Following Rheomuco’s first sales to research laboratories in Europe, Rheonova wishes to boost its commercial activity.

And to bring Rheomuco to the patient’s bedside, 2 new clinical trials are underway. The first at Cochin Hospital for patients with cystic fibrosis and the second for COPD (Chronic Obstructive Pulmonary Disease).

To achieve these objectives, Rheonova must strengthen its equity capital, the amount sought through the  crowdfunding campaign on Sowefund is around €500k, which will be supplemented by €352k through the Innovation Competition.

Watch the video.

Read the press release (in french).